Dyne Therapeutics, Inc. (DYN) income statement
DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$15.87−0.15 (-0.94%)
Close on Nov 18, 2026Market cap $2.96BP/E –Yield –
Dyne Therapeutics, Inc. financial ratios
See a number that looks wrong?